$0.980000
-0.0077-0.79%
At close: Sep 19, 7:59 PM EDT
$0.972300
-0.0077-0.79%
After Hours: 7:59 PM EDT
15 minutes delayed
Hoth Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Hoth Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Mar 2024 | 2024-05-14 | $-0.46 | $-0.43 | -6.98 % |
Dec 2023 | 2024-03-28 | $-0.31 | $-0.51 | 39.2 % |
Sep 2023 | 2023-11-13 | $-0.60 | $-0.72 | 16.7 % |
Jun 2023 | 2023-08-12 | $-0.57 | $-1.16 | 50.9 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Hoth Therapeutics (HOTH) is scheduled to report earnings on November 11, 2024. The last reported earnings were for reported on May 14, 2024 for Q1.
The Actual EPS was $-0.46, which missed the estimate of $-0.43.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.